Amicus Therapeutics Inc FOLD

NAS: FOLD | ISIN: US03152W1099 6/02/2026

14,30 USD (+0,14%)

(+0,14%) 6/02/2026

Grafiek Amicus Therapeutics Inc

Grafiek Amicus Therapeutics Inc

1 dag1d 0,14%
1 week1w 0,07%
1 maand1m 0,14%
3 maanden3m 58,89%
6 maanden6m 111,54%
1 jaar1j 48,34%
5 jaar5j -28,00%

Amicus Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

19 december 2025 · BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook · Persbericht

10 juli 2025 · SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term FOLD Investors to Contact the Firm · Persbericht

11 februari 2021 · Amicus’ AT-GAA Shows Clinically Meaningful & Significant Improvements in Both Musculoskeletal and Respiratory Measures in Late-Onset Pompe Disease Compared to Standard of Care in Pivotal Phase 3 PROPEL Study · Persbericht

8 februari 2021 · Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium™ 2021 · Persbericht

8 februari 2021 · Amicus Therapeutics Presents Positive Preclinical Fabry Disease Gene Therapy Data at the 17th Annual WORLDSymposium™ 2021 · Persbericht

21 januari 2021 · Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021 · Persbericht

Profiel Amicus Therapeutics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.amicusrx.com

Hoofdzetel: Cranbury, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe